Resection of Isolated Brain Metastases in Non-small Cell Lung Cancer (NSCLC) Patients - Evaluation of Outcome and Prognostic Factors: A Retrospective Multicenter Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2021 Jun 28

PMID 34181677

Citations 14

Authors

Julia Fuchs

Martin Fruh

Alexandros Papachristofilou

Lukas Bubendorf

Pirmin Hauptle

Lorenz Jost

Alfred Zippelius

Sacha I Rothschild

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Brain metastases occur in about 30% of all patients with non-small cell lung cancer (NSCLC). In selected patients, long-term survival can be achieved by resection of brain metastases. In this retrospective study, we investigate the prognosis of NSCLC patients with resected brain metastases and possible prognostic factors.

Methods: In 119 patients with NSCLC and resected brain metastases, we report the following parameters: extent of resection, resection status, postoperative complications and overall survival (OS). We used the log-rank test to compare unadjusted survival probabilities and multivariable Cox regression to investigate potential prognostic factors with respect to OS.

Results: A total of 146 brain metastases were resected in 119 patients. The median survival was 18.0 months. Postoperative cerebral radiotherapy was performed in 86% of patients. Patients with postoperative radiotherapy had significantly longer survival (median OS 20.2 vs. 9.0 months, p = 0.002). The presence of multiple brain metastases was a negative prognostic factor (median OS 13.5 vs. 19.5 months, p = 0.006). Survival of patients with extracerebral metastases of NSCLC was significantly shorter than in patients who had exclusively brain metastases (median OS 14.0 vs. 23.1 months, p = 0.005). Both of the latter factors were independent prognostic factors for worse outcome in multivariate analysis.

Conclusions: Based on these data, resection of solitary brain metastases in patients with NSCLC and controlled extracerebral tumor disease is safe and leads to an overall favorable outcome. Postoperative radiotherapy is recommended to improve prognosis.

Citing Articles

Cancer brain metastasis: molecular mechanisms and therapeutic strategies.

Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H Mol Biomed. 2025; 6(1):12.

PMID: 39998776 PMC: 11861501. DOI: 10.1186/s43556-025-00251-0.

Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research.

Sampat P, Cortese A, Goodman A, Ghelani G, Mix M, Graziano S Front Oncol. 2024; 14:1411432.

PMID: 39534096 PMC: 11554526. DOI: 10.3389/fonc.2024.1411432.

Heterogeneity and prognosis of single organ metastases in gastric cancer.

Zhao Q, Quan Z, Liu S, Wang Y, Guo H Transl Gastroenterol Hepatol. 2024; 9:61.

PMID: 39503034 PMC: 11535815. DOI: 10.21037/tgh-24-11.

GABA(A) Receptor Activation Drives GABARAP-Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma Tumors.

Bhattacharya D, Barrile R, Toukam D, Gawali V, Kallay L, Ahmed T Cancers (Basel). 2024; 16(18.

PMID: 39335139 PMC: 11430345. DOI: 10.3390/cancers16183167.

Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients.

Hosoya K, Ozasa H, Tanji M, Yoshida H, Ajimizu H, Tsuji T BMC Cancer. 2024; 24(1):1030.

PMID: 39169327 PMC: 11337764. DOI: 10.1186/s12885-024-12798-2.

References

Sperduto P, Yang T, Beal K, Pan H, Brown P, Bangdiwala A . Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2016; 3(6):827-831. PMC: 5824323. DOI: 10.1001/jamaoncol.2016.3834. View

Patchell R, Tibbs P, Walsh J, Dempsey R, Maruyama Y, Kryscio R . A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322(8):494-500. DOI: 10.1056/NEJM199002223220802. View

Soffietti R, Abacioglu U, Baumert B, Combs S, Kinhult S, Kros J . Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol. 2017; 19(2):162-174. PMC: 5620494. DOI: 10.1093/neuonc/now241. View

Billing P, Miller D, Allen M, Deschamps C, Trastek V, Pairolero P . Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg. 2001; 122(3):548-53. DOI: 10.1067/mtc.2001.116201. View

Eitz K, Lo S, Soliman H, Sahgal A, Theriault A, Pinkham M . Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases. JAMA Oncol. 2020; 6(12):1901-1909. PMC: 7563677. DOI: 10.1001/jamaoncol.2020.4630. View

Sundaresan N, Galicich J . Surgical treatment of brain metastases. Clinical and computerized tomography evaluation of the results of treatment. Cancer. 1985; 55(6):1382-8. DOI: 10.1002/1097-0142(19850315)55:6<1382::aid-cncr2820550637>3.0.co;2-z. View

Brega K, Robinson W, Winston K, Wittenberg W . Surgical treatment of brain metastases in malignant melanoma. Cancer. 1990; 66(10):2105-10. DOI: 10.1002/1097-0142(19901115)66:10<2105::aid-cncr2820661011>3.0.co;2-i. View

Mahajan A, Ahmed S, McAleer M, Weinberg J, Li J, Brown P . Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017; 18(8):1040-1048. PMC: 5560102. DOI: 10.1016/S1470-2045(17)30414-X. View

Furak J, Trojan I, Szoke T, Agocs L, Csekeo A, Kas J . Lung cancer and its operable brain metastasis: survival rate and staging problems. Ann Thorac Surg. 2004; 79(1):241-7. DOI: 10.1016/j.athoracsur.2004.06.051. View

10.

Mussi A, Pistolesi M, Lucchi M, Janni A, Chella A, Parenti G . Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. J Thorac Cardiovasc Surg. 1996; 112(1):146-53. DOI: 10.1016/s0022-5223(96)70190-3. View

11.

Auchter R, Lamond J, Alexander E, Buatti J, Chappell R, Friedman W . A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996; 35(1):27-35. DOI: 10.1016/s0360-3016(96)85008-5. View

12.

Patchell R, Tibbs P, Regine W, Dempsey R, Mohiuddin M, Kryscio R . Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998; 280(17):1485-9. DOI: 10.1001/jama.280.17.1485. View

13.

Bindal R, Sawaya R, LEAVENS M, Hess K, Taylor S . Reoperation for recurrent metastatic brain tumors. J Neurosurg. 1995; 83(4):600-4. DOI: 10.3171/jns.1995.83.4.0600. View

14.

Roos D, Wirth A, Burmeister B, Spry N, Drummond K, Beresford J . Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiother Oncol. 2006; 80(3):318-22. DOI: 10.1016/j.radonc.2006.08.004. View

15.

Chao S, de Salles A, Hayashi M, Levivier M, Ma L, Martinez R . Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline. Neurosurgery. 2017; 83(3):345-353. DOI: 10.1093/neuros/nyx522. View

16.

Getman V, Devyatko E, Dunkler D, Eckersberger F, End A, Klepetko W . Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment. Eur J Cardiothorac Surg. 2004; 25(6):1107-13. DOI: 10.1016/j.ejcts.2004.02.021. View

17.

Burt M, Wronski M, Arbit E, Galicich J . Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. J Thorac Cardiovasc Surg. 1992; 103(3):399-410; discussion 410-1. View

18.

Muacevic A, Kreth F, Horstmann G, Schmid-Elsaesser R, Wowra B, Steiger H . Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg. 1999; 91(1):35-43. DOI: 10.3171/jns.1999.91.1.0035. View

19.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

20.

Shin D, Na I, Kim C, Park S, Baek H, Yang S . EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol. 2014; 9(2):195-9. DOI: 10.1097/JTO.0000000000000069. View